More Than Just Humira: US Biosimilars Enjoy An Eventful 2023

Adalimumab Competition Hits, Firms Settle On Stelara And New First Biosimilars Approved

 
• By David Wallace
  
2023 date with arrow on metal dial
Several Humira biosimilars launched simultaneously in 2023

More from Biosimilars

More from Products